首页 | 本学科首页   官方微博 | 高级检索  
检索        

肥胖大鼠血清C反应蛋白水平的动态变化及罗格列酮干预的影响
引用本文:姚辉,林汉华,于芳,黄晓燕,夏治.肥胖大鼠血清C反应蛋白水平的动态变化及罗格列酮干预的影响[J].临床内科杂志,2004,21(8):561-563.
作者姓名:姚辉  林汉华  于芳  黄晓燕  夏治
作者单位:1. 武汉市儿童医院内科
2. 430030,武汉,华中科技大学同济医学院附属同济医院
摘    要:目的 观察高脂喂养的肥胖大鼠模型胰岛素抵抗出现的时间、程度的变化及C反应蛋白 (CRP)水平的动态变化 ;观察罗格列酮对高脂肥胖大鼠血清CRP水平的影响。方法  3 0只清洁级雄性Wistar大鼠按体重随机分成正常对照组、肥胖组和罗格列酮治疗组。肥胖组和治疗组以高脂饮食喂养 2 0周 ,制成肥胖模型。于实验过程的第 10、2 0、2 4周分别取血检测空腹血糖、空腹胰岛素和血清CRP。CRP检测用免疫散射比浊法测定。结果 与正常对照组比较 ,高脂喂养大鼠第10周已出现胰岛素抵抗 ,并逐渐加重。同时 ,肥胖组血清CRP水平也逐渐升高 ,第 2 0周明显高于第 10周 (P <0 .0 5 )。至 2 4周 ,肥胖组、治疗组大鼠血清CRP水平明显高于正常组 (分别为P <0 .0 1,P <0 .0 5 ) ,治疗组低于肥胖组 (P <0 .0 5 )。血清CRP水平与胰岛素敏感性指数、甘油三酯呈正相关关系 (r =0 .3 5 9,P <0 .0 5 ;r =0 .482 ,P <0 .0 1)。结论 随着胰岛素抵抗的加重 ,血清CRP水平逐渐升高 ,罗格列酮治疗可改善胰岛素抵抗 ,降低CRP水平

关 键 词:C反应蛋白  肥胖  胰岛素抵抗  罗格列酮
文章编号:1001-9057(2004)08-0561-03
修稿时间:2004年3月22日

Dynamic changes of serum C-reaction protein levels in diet-induced obese rats and effect of rosiglitazone intervention
YAO Hui,LING Hanhua,YU Fang,et al..Dynamic changes of serum C-reaction protein levels in diet-induced obese rats and effect of rosiglitazone intervention[J].Journal of Clinical Internal Medicine,2004,21(8):561-563.
Authors:YAO Hui  LING Hanhua  YU Fang  
Institution:YAO Hui,LING Hanhua,YU Fang,et al.Department of Pediatrics,Tongji hospital affiliated to Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Abstract:Objective To observe dynamic changes of insulin resistance,serum C-reaction protein levels in diet-induced obese rats and effect of rosiglitazone intervention.Methods Thirty SPF level Wistar male rats of age 2-3 weeks were divided into 3 group randomly:the normal control group,fat group and the rosiglitazone-treatment fat group.After 20 weeks high fat diet feeding get fat models.The serum CRP concentration was detected in the 10th,20th,24th week with immunoscattering assay.Results Insulin resistance of the fat-feed rats started in the 10th week,and increased gently.At the same time,the serum CRP increased with the insulin resistance.The serum CRP levels of fat group and rosiglitazone-treatment fat group in the 24th week were significantly higher than the normal control group(P<0.01,P< 0.05).The serum CRP levels in the rosiglitazone-treatment fat group were decreased(P<0.05).The serum CRP concentration was positively correlated with insulin sensitivity index(r=-0.359,P<0.05),Triglyceride(r=0.482,P<0.01).Conclusion The serum CRP concentration gradually increased with worsening of insulin resistance.Rosiglitazone improved insulin resistance,decreased the serum CRP levels.
Keywords:C-reaction protein  Obesity  Insulin resistance  Rosiglitazone
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号